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Abstract
Visual fields measured with standard automated perimetry are a benchmark test for determining retinal function in ocular
pathologies such as glaucoma. Their monitoring over time is crucial in detecting change in disease course and, therefore, in
prompting clinical intervention and defining endpoints in clinical trials of new therapies. However, conventional change
detection methods do not take into account non-stationary measurement variability or spatial correlation present in these
measures. An inferential statistical model, denoted ‘Analysis with Non-Stationary Weibull Error Regression and Spatial
enhancement’ (ANSWERS), was proposed. In contrast to commonly used ordinary linear regression models, which assume
normally distributed errors, ANSWERS incorporates non-stationary variability modelled as a mixture of Weibull distributions.
Spatial correlation of measurements was also included into the model using a Bayesian framework. It was evaluated using a
large dataset of visual field measurements acquired from electronic health records, and was compared with other widely
used methods for detecting deterioration in retinal function. ANSWERS was able to detect deterioration significantly earlier
than conventional methods, at matched false positive rates. Statistical sensitivity in detecting deterioration was also
significantly better, especially in short time series. Furthermore, the spatial correlation utilised in ANSWERS was shown to
improve the ability to detect deterioration, compared to equivalent models without spatial correlation, especially in short
follow-up series. ANSWERS is a new efficient method for detecting changes in retinal function. It allows for better detection
of change, more efficient endpoints and can potentially shorten the time in clinical trials for new therapies.
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Background and Significance
In recent years great strides have been made in understanding
ocular diseases in the research laboratory and in vivo, leading to the
elucidation of neuro-regenerative processes and even reversing
blindness in some conditions.[1–4] The retina, uniquely, is an
accessible and directly visible extension of the brain and, therefore,
retinal research is becoming a focus for unravelling the complexity
of other neurological changes such as those observed in
Alzheimer’s disease,[5,6] multiple sclerosis [7,8] and Gaucher
disease.[9] The primary goal in the management of most eye
conditions is preservation or improvement in visual function. An
established reference test for visual function, namely the visual
field, is Standard Automated Perimetry (SAP; Figure 1a). SAP
measures the differential light sensitivity (DLS), across a person’s
retina and the corresponding visual pathway (Figure 1b,c).
Unfortunately, development of computational and statistical
methods for analysing data from SAP has not kept pace with the
advances in other aspects of eye-related research. Nevertheless,
SAP is used extensively in eye and neurology clinics, especially in
the detection and management of glaucoma, a group of chronic
optic neuropathies causing progressive loss of retinal ganglion cells
and their axons and resulting in loss of retinal function. This
disease represents a large global health problem with about 80
million people expected to be affected by 2020.[10,11] Glaucoma
stability on treatment is assessed by monitoring the visual field with
SAP tests, repeated at intervals of between 2 months and 2 years
over a patient’s lifetime. Computational methods are required to
analyse series of SAP data to identify change; without these, even
experienced clinicians have been shown to make inconsistent
decisions.[12,13] Current statistical approaches typically use
ordinary least squares regression over time to track changes in
summary measures, regions of interest or individual visual field
locations.[14–17] Other methods simply make comparisons
between the most recent test(s) and baseline measurements.[18]
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Current methods for detecting change in series of DLS
measurements are inadequate because they do not sufficiently
address the complexity of the data,[19] notably non-stationary
variability and spatial correlation. SAP measurements of retinal
function are indirect because of the psychophysical processes
involved – a person’s response depends on the probability of
perceiving and responding to a light stimulus (Figure 1d). The
consequence is considerable variability that increases as DLS
deteriorates with the disease progresses, eventually becoming
censored in blind regions.[20–22]. For instance, when DLS is
healthy at 32 dB, the repeat measurement range (90% confidence
interval) is 7 dB (26 dB to 33 dB), while this range increases to
18 dB (5 dB to 27 dB) when the DLS deteriorates to 20 dB. This
changing variability over time is referred to as ‘non-stationary
measurement variability’. Furthermore, SAP measurements are
made in a regular grid across a patient’s field of view, but this grid
does not respect the anatomical arrangement of the retinal nerve
fibres that transmit signals from the retina to the brain
(Figure 1c).[23] The division of the grid by retinal nerve fibres
results in correlation between spatially-related locations. There are
prescriptions for modelling this unique spatial process,[24] but
they have yet to be incorporated into analysis of series of SAP
measurements over time. Therefore, without taking into account
these statistical properties, detection of change in retinal function
with current methods is often delayed, or requires more clinic visits
than should be necessary.[25]
Figure 1. Visual field measured by standard automated perimetry (SAP). (a) Contrast stimulus from SAP is projected on different locations
of retina. The response from subject is captured when the stimulus is perceived. (b) SAP assesses differential light sensitivity (DLS) of the retina and
corresponding visual pathway. (c) DLSs are measured at various locations (dots) on the retina. The point (0u,0u) indicates central vision that
corresponds to the fovea on the retina. Optic nerve head is the anatomical blind spot. The test locations are not only correlated to their neighbours
but also by the optic nerve fibres (some of which are shown as blue curves) passing through them. The whole visual field can be divided into superior
and inferior hemifields on vertical and nasal and temporal regions on horizontal. (d) The DLS at a location on the retina is derived at the 50%
probability of the visual system responding to a contrast stimulus and is related to the biological response to light of relay neurones in the visual
pathway. (e) The DLS is measured in log scale, which in Humphrey Field Analyzer (Carl Zeiss Meditec Inc, Dublin, CA, USA) is calculated as
dB= 10 log10 10000= A{31:6ð Þð Þ where A is the luminance of the stimulus in apostilbs and 31.6 apostilbs is the background luminance. The DLS
ranges between 0 dB (high contrast stimulus, blindness) and around 35 dB (low contrast stimulus, healthy) and is displayed as a conventional gray-
scale plot. Darker shading represents lower DLS. (f) Measurements of DLS over time form a complex spatial-temporal time series.
doi:10.1371/journal.pone.0085654.g001
Detecting Changes in Retinal Function: ANSWERS
PLOS ONE | www.plosone.org 2 January 2014 | Volume 9 | Issue 1 | e85654
To address these issues we propose an analytical approach to
handle the variability structure in SAP data and also capture the
information about the spatial process underpinning changes in the
visual field. This new computational method, analysis with non-
stationary Weibull error regression and spatial enhancement
(ANSWERS), is designed to accurately identify changes in SAP
measurements acquired over time (Figure 1f). Further, the method
can be adapted to investigations of new therapies, so that changes
before and after an intervention can be detected. In this study we
applied the technique to large scale clinical data sampled from
more than 75,000 patients in electronic health records. Specif-
ically, we examine the hypothesis that ANSWERS can detect
change in retinal function more rapidly than widely used methods
based on ordinary least squares linear regression.
Materials and Methods
Ethics statement
Patients’ data was anonymised prior to investigation and did not
contain personal or sensitive information. It was held in a secure
database held at City University London. As such patients’ written
consent for their data to be used in the study was not required.
The study adhered to the tenets of the Declaration of Helsinki and
was approved by the research governance committee of City
University London, United Kingdom. The anonymised dataset
can be accessed upon request.
Datasets
All visual fields were measured via SAP with the Humphrey
Field Analyzer (Carl Zeiss Meditec, CA, USA) using the 24-2 test
pattern (Figure 1c) and the SITA (Swedish Interactive Thresh-
olding Algorithm) Standard testing algorithm. The test measures
retinal DLS at about 50 test locations, where each test location is
evenly separated by an angular distance of 6u across the visual field
(Figure 1c).
Two datasets collected at different centres were used in this
study. The first dataset was sampled from 402,357 visual fields of
75,857 patients from electronic health records of glaucoma clinics
at Moorfields Eye Hospital in London. DLS deteriorates as a result
of ageing, and typically do not increase in response to standard
medical treatments for glaucoma. Thus, all series in the dataset
should be worsening at a rate at least equal to age-related decline.
When positive rates are observed, in the case of glaucoma, this is
usually due to ‘learning effects’ (patients learn to perform the visual
field test) or the inherent variability of the measurement.
Therefore, the first visual field of each series was discarded to
reduce the impact of ‘learning effects’.[26,27] If multiple visual
fields were taken on the same day, the last measurement was
chosen. Only series that were obtained over 6 years and contained
at least 7 visual fields were included in the study. Note that the
length of series is purely for evaluation purposes and is not
necessitated by the proposed model. All series meeting the above
criterion were selected for this study and the resulting dataset
consisted of 47,483 visual field tests from 6,011 series from 6,011
eyes, representing about 2.5 million individual DLS measure-
ments. The median (interquartile range [IQR]) time of follow up
was 9.3 (7.9, 10.4) years and the median (IQR) number of visual
fields in each time series was 9 (8, 11). The median (IQR) interval
between visual field tests was 1.0 (0.6, 1.4) years.
The second dataset was from a study examining the ‘test-retest’
variability of SAP conducted at Dalhousie University, Halifax
Canada in a cohort of glaucoma patients. Changes in retinal
function are slow in glaucoma. By taking repeat measurements in
a short period of time, it is possible to estimate measurement test
variability, under the assumption that no measurable deterioration
can occur over the observation period.[20] One eye of 30 patients
was tested 12 times over a short period (maximum 8 weeks), during
which no measureable deterioration may happen. The variance
among visual fields in these repeat measures indicates the inherent
measurement variability. Furthermore, each of these visual field
series, and the same series with arbitrary reordering, represents a
‘stable’ series with no underlying deterioration. The use of
randomly reordered series for estimates of measurement variability
is an established method used in various studies.[28,29]
Computational model
Modelling measurement variability with a mixture of
Weibull distributions. The variability of individual DLS
measurements can be estimated by repeating visual field tests in
a short period of time.[20] The test-retest dataset consisting of
1980 (30C212, i.e. 30 multiplied by 12-choose-2 combinations) pairs
of repeated visual field tests was used to estimate the retest
distributions for DLS measurements ranging from 0 dB to 35 dB.
Retest distributions are generally bimodal, truncated and skewed;
the shape of the distribution varies dramatically across the range of
DLS measurements due to the non-stationary variability and the
censored nature of the DLS measurement.[22] As the retest
distribution could not be sufficiently described by a single
parametric probability density function, at each integer level of
DLS, it was modelled as a mixture of Weibull distributions. The
Weibull distribution was chosen due to its versatility and relative
simplicity. In comparison with commonly used Gaussian distribu-
tion, it is a more proper option for modelling probability
distribution of non-negative variables like DLS. Its probability
density function is defined by two parameters, a and b:
weibull xja,bð Þ~
a
b
x
b
 a{1
e
{ x
b
 a
x§0
0 xv0
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For K Weibull mixture components and N retest data points
xnf gNn~1, a latent K-dimensional binary vector variable zn defines
to which mixture component the data point xn belongs. The kth
element znk~1 if xn belongs to the kth component, otherwise
znk~0. With the prior probability,
p znk~1ð Þ~pk ð2Þ
the complete likelihood of observed and latent variables becomes:
p x,Zjp,a,bð Þ~P
n
P
k
pkweibull xnjak,bkð Þð Þznk ð3Þ
where p~ pkf gKk~1 with pk being the prior probability that xn
belongs to the kth mixture component so
P
k
pk~1. x~ xnf gNn~1,
Z~ znf gNn~1, a~ akf gKk~1 and b~ bkf gKk~1 where ak and bk are
the parameters defining the kth Weibull mixture component.
Marginalising (3) over Z gives the likelihood of Weibull mixture
distribution:
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The maximisation of (4) does not give closed solution for
parameters p, a and b. Therefore, an expectation-maximisation
algorithm [30] was derived to iteratively optimise (4). The detailed
model derivation is given in Appendix S1. Moreover, to select the
number of mixture components, K was increased from 1 until the
logarithm of likelihood in (4) no longer increases with statistical
significance (p,1%) in cross validations.
Further, since the log Weibull distribution for the minimum DLS
in visual field testing, 0 dB, is undefined, a DLS v was transformed
to s vð Þ such that:
s vð Þ~ v v§1
exp v{1ð Þ vv1

ð5Þ
Note that s vð Þ is v itself except when vv1 and the lower bound
for s vð Þ is 0 dB. This transformation guarantees that the
transformed DLS s vð Þ is continuous and has a first derivative,
which is an important property for the optimisation of the
regression model described in the next section.
For notational simplicity, the derived retest distribution (4) for
DLS y will hereafter be denoted as Ry :ð Þ.
Analysis with non-stationary Weibull error regression
and spatial enhancement (ANSWERS). We propose a meth-
od to monitor change in measurement series, named ANSWERS.
The proposed model is based on the mixture of Weibull retest
distributions outlined above, and incorporates spatial correlation
within the data.
Given Q visual field measurements (each with M test locations)
in a time series at time tif gQi~1, yij represents a measurement at
time ti and location j. To formulate the regression model in a
compact notation, let yi~ yij
n oM
j~1
, Y~ yif gQi~1, a column vector
ti~½ti,1T and t~ tif gQi~1.
The regression model is defined by weight vectors wj
 M
j~0
for
each of the M test locations in the measurement. Each weight
vector wj contains a slope and intercept for the jth location
regressed over time in the case of a linear model. For simplicity of
notation,W~ wj
 M
j~0
was used to refer to collection of all weight
vectors. The likelihood for all visual field measurements in the time
series Y becomes:
p YjW,tð Þ~P
Q
i~1
p yijW,tið Þ
~P
Q
i~1
P
M
j~1
Ryij s w
T
j ti
   ð6Þ
where Ryij
:ð Þ and s :ð Þ were defined in (4) and (5) respectively. Note
that p YjW,tð Þ can be factorised into the product of p yijW,tið Þ for i
from 1 to Q because yi is conditionally independent of other
measurements in the series given W.
To incorporate the spatial correlation among different locations
in the measurement, prior distributions of slope and intercepts
were defined to be multivariate normal distributions:
p wað Þ~N wajma,aSð Þand
p wbð Þ~N wbjmb,bSð Þ
ð7Þ
where wa and wb are the slopes and intercepts of the regression
lines respectively. ma and mb are the means of respective normal
distributions and S is the covariance matrix scaled by a and b.
The unscaled covariance matrix S encodes the spatial
correlation among test locations in the measurement. The element
Spq on the pth row and qth column represents the strength of
correlation between points p and q in the visual field. For visual
field DLS measurements investigated in this study, Spq was defined
as:
Spq~
exp {
1
2
dist2pq
d2d
z
%2pq
d2%
 ! !
if p and q are in
the same hemifield
0 otherwise
8><
>: ð8Þ
where distpq is the Euclidian distance between the points p and q
in the visual field, and %pq is the difference between the angles
that the optic nerve fibres crossing points p and q enter the optic
nerve head.[23,24] dd and d% are scale parameters chosen to be
dd~6
0 and d%~14
0. Specifically, dd~6
0 is the distance between
two neighbouring points in the visual field and d%~14
0 is the
reported 95% confidence interval of population variability in the
nerve fibre entrance angle into the optic nerve head.[23] Note that
Spq~0 if the two points lie on different hemifields (upper or lower;
Figure 1c) of the visual field due to the physiological distribution of
optic nerve fibres.[23] The unscaled covariance S between each
location in the visual field and all other points is illustrated in
Figure 2. ANSWERS, in this study, has been specifically adapted to
detect deterioration in glaucoma, so the spatial correlation S here
encodes the anatomy of optic nerve fibres. To adapt ANSWERS for
other types of measurement corresponding to different diseases or
conditions, S should be adjusted to reflect the characteristics of the
spatial correlation present in that data.
The values for the scale parameters a and b were chosen to
produce non-informative priors for wa and wb. To be exact, the
slope prior was set as ma~0(dB/year) with a~10
2 corresponding
to a slope standard deviation of 10 dB/year. The intercept prior
was set such that mb~18dB (middle of DLS measurement range)
and b~102corresponding to an intercept standard deviation of
10 dB.
According to (6) and (7), the log of posterior probability of W
can be derived as:
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ln p WjY,tð Þ~ ln
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where L{1a ~aS, L
{1
b ~bS. The terms independent of W are
grouped into the constant term, const.
The posterior probability (9) cannot be recognised as a known
distribution because (7) is not the conjugate prior of the mixture of
Weibull distributions. Although the log posterior (9) can still be
maximised with regard to W, it is difficult to estimate the exact
variance of W without knowing the underlying distribution.
Therefore, a Laplace approximation [31,32] was used to approx-
imate p WjY,tð Þ as a normal distribution centred at the mode of
W, as described in Appendix S1. The estimates of the slope and
intercept in the Laplace method exactly match the local maximum
of log posterior probability (9). However, the variance of these
slopes and intercepts are approximate estimates.
For the purpose of evaluating the effects of spatial correlation,
its contribution can be ‘switched off’ by setting the off-diagonal
elements of S in (7) to be 0. This model without spatial
enhancement is denoted as ANSWER.
ANSWERS indices: identification of change. ANSWERS
estimates the slope wa and intercept wb with their variance
approximated by the Laplace method. The distribution of the slope
is of particular clinical importance because it represents the rate
and certainty of change. The ‘change’ applies equally to
deterioration (negative change) and improvement (positive change)
in measurements. In the case of a progressive condition, such as
glaucoma, the slope distribution at each location can be
summarised as the ‘probability of no-deterioration’, which is
quantified as the cumulative distribution of slope $0 dB/year.
The ‘probability of no-deterioration’ value will be referred to as
Pnd hereafter. The Pnd value ranges between 0 and 1 where a
lower value indicates a higher probability of deterioration.
In order to summarise the possibility of deterioration across all
M test locations in the visual field series, a global index, the
ANSWERS deterioration index I{, is defined as:
Figure 2. Spatial correlation S between each location and all other locations in the visual field. The composition of the graph is a 24-2
visual field as shown in Figure 1c. At each visual field location, an image, with the shape of a 24-2 visual field, represents the correlation between this
location and all locations in the visual field. The grayscale bar, shown at the location of the blind spot, indicates the level of correlation.
doi:10.1371/journal.pone.0085654.g002
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I{~{
XM
j~1
lnPndj ð10Þ
where Pndj is the Pnd value at the jth location in the measurement.
I{ is the negative logarithm of the product of all Pnd values, thus,
non-negative and larger value implies greater certainty about
deterioration in the measurement series. Similarly, to evaluate the
improvement in a measurement series, such as in the case of gene
therapy for retinal disease,[3] the ANSWERS improvement index
Iz can be derived as Iz~{
PM
j~1
ln 1{Pndj
	 

. However, because
this study illustrates the application on identifying deterioration in
retinal function in glaucoma, the ANSWERS index will henceforth
only refer to I{.
Evaluation
To evaluate the utility of ANSWERS in detecting retinal function
change, it is necessary to compare it to other change detection
methods currently used in clinical decision making. Point-wise
linear regression, the most widely used method, fits an ordinary
linear regression model to a time series of measurement for each
location in the visual field and assesses the significance and slope of
the fit. Summary measures, such as the mean deviation from the
average DLS of healthy eyes, are also utilised, but since glaucoma
tends not to affect all locations to the same extent, global indices
often have inadequate statistical sensitivity to detect worsening
when compared with methods assessing deterioration at individual
locations.[14–17]. Moreover, to evaluate the benefit of taking into
account non-stationary variability and spatial correlation respec-
tively, ANSWERS without spatial enhancement (ANSWER) was
also evaluated. Thus, ANSWERS was compared with three other
methods: ordinary linear regression of mean deviation, point-wise
linear regression and ANSWER.
Estimation of false positive rates. A false positive is a type
I error where change is falsely detected in a series with no true
deterioration. The false positive rate can be reliably estimated in a
series of repeated measurements acquired in a period of time too
short for measureable deterioration. Moreover, randomly reor-
dering these repeated measurements produces pseudo-series where
there is also no true deterioration.
The series of 12 visual fields from 30 eyes in the test-retest
dataset were randomly reordered 300 times, so 90,000 pseudo-
series of length between 3 and 12 were generated. It was assumed
that one visual field measurement per year was taken in these
pseudo series (the median test frequency in the Moorfields dataset).
The false positive rate was then estimated as the proportion of
series identified as deteriorating. In a clinical situation, false
positives may lead to overtreatment and unnecessary cost, so
methods with high false positive rates are generally considered as
not clinically useful.
Different methods should be compared at equivalent false
positive rates, which is dependent on the chosen change criterion
and the length of the series. For ordinary linear regression of mean
deviation, deterioration criteria were a negative slope and p-value
lower than a set threshold. For point-wise linear regression,
deterioration criteria for each test location were a negative slope
and a p-value,1% and the visual field was worsening when at least
n = 1, 2, 3 and 4 contiguous points were deteriorating. For
ANSWERS and ANSWER, the criterion for deterioration was a I{
value higher than a given threshold. For each method, a set of
thresholds was chosen to achieve specified false positive rates, and
the performance of each method was then compared at equivalent
false positive rates.
Time to detect change. The time to detect deterioration was
compared between methods using the dataset from electronic
health records at Moorfields Eye Hospital. In each visual field
series, a subseries containing the first three visual fields was
considered as the minimum series length required to detect
change. The length of the subseries was then increased by
incrementally adding visual fields to the subseries in chronological
order. The shortest series that was flagged as deteriorating was
then recorded for each method. If no deterioration was detected in
any subseries of a visual field series by a method, the time was
recoded as the total time span of the series. The comparison
among different methods was carried out at equal false positive
rates.
Hit rate of change detection. Statistical sensitivity is the
measure of a method’s ability to identify true change. Ideally, the
sensitivity should be evaluated as the proportion of detected
change in the visual field series with true underlying deterioration.
However, due to the lack of a ‘gold-standard’ and ‘ground-truth’
classification for glaucomatous deterioration,[33] the underlying
worsening status of each visual field series was unknown.
Therefore, the methods were compared using the ‘hit rate’, which
is the proportion of series flagged as deteriorating in the
Moorfields dataset. Given an unknown proportion p% of truly
worsening series in the dataset, the hit rate is linked to statistical
sensitivity as: hit rate = (p%6sensitivity)+[(12p%)6false positive
rate]. Note that if the false positive rate is controlled to be
equivalent for all methods, a higher hit rate implies better
sensitivity of a method. Therefore, hit rates of all methods were
compared as a surrogate comparison for sensitivity.
Results
ANSWERS was implemented in MATLAB R2013a (Math-
Works Inc., Natick, MA). Analysis of a series with 10 visual fields
took approximately 1.5 seconds on a 2.50 GHz Intel i7 processor.
The software is freely available from the authors.
Mixture of Weibull retest distributions
At all levels of DLS, increasing the number of Weibull mixture
components to be more than 2 does not significantly increase the
log likelihood (4) in cross validations. Therefore, two mixture
components were used to model retest distribution for sensitivities
between 0 dB and 35 dB. The histograms and the derived
probability density functions of the Weibull mixture at different
DLSs are shown in Figure 3. Despite the non-stationary
variability, each distribution can be sufficiently described by a
combination of two Weibull distributions.
The examples in Figure 4 demonstrate the effect of the Weibull
mixture retest distribution used by ANSWER in comparison to
ordinary linear regression in series of DLSs at a single visual field
location. Because only a single visual field location was considered
for illustrative purposes, there is no spatial enhancement in these
examples. In Figure 4a, the last measurement in the series changes
suddenly due to measurement variability leading to a steep slope
using ordinary linear regression. By comparison, ANSWER is less
affected by the last measurement since it accounts for the large
variability associated with measurements at this level of DLS, and
results in a shallower slope. This property of ANSWER makes it
robust to the non-stationary variability of DLS measurements and,
therefore, a more reliable estimator of change rate.
Detecting Changes in Retinal Function: ANSWERS
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Time to detect change
Despite the robustness of ANSWER, it does not compromise
sensitivity to detect deterioration. In fact, by taking into account
the non-stationary variability of DLS measurements, the method is
able to detect significant deterioration in short time series where
conventional methods cannot reach statistical significance. In
Figure 4b, ordinary linear regression did not indicate significant
deterioration (p-value.5%), while ANSWER managed to ascertain
with high certainty that deterioration was occurring (Pnd,0.1%).
This property allows ANSWER to provide better time efficiency in
detecting deterioration.
Figure 5 shows the average time to first detect deterioration in
the visual field series with each method at false positive rates
between 0 and 15% (methods with a higher false positive rate are
not clinically useful). Because the criteria for point-wise linear
regression (the number of contiguous points with deterioration in
the visual field) are not continuous, the time efficiency of point-
wise linear regression could not be estimated with a continuous
false positive rate. Moreover, the false positive rate with the single-
point criterion of point-wise linear regression was higher than
15%, so this was not shown in the figure.
For each method, the time to detection change was compared at
the 5% false positive rate, or at the closest rate to 5% for point-
wise linear regression (two contiguous points, false positive rate of
5.3%). At this false positive rate, ANSWER detected deterioration
faster than point-wise linear regression (p,0.1% paired t-test) and
linear regression of mean deviation (p,0.1% paired t-test).
Furthermore, with spatial enhancement, ANSWERS was able to
detect deterioration significantly faster than ANSWER (p,0.1%
paired t-test). On average, ANSWERS detected deterioration 2.42
(95% confidence interval [2.35, 2.49]) years ahead of point-wise
Figure 3. Histograms of retest differential light sensitivities at levels between 0 dB and 35 dB. The derived probability density function
of the Weibull mixture is superimposed in red.
doi:10.1371/journal.pone.0085654.g003
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linear regression, 2.28 (95% confidence interval [2.20, 2.35]) years
before linear regression of mean deviation, and 0.27 (95%
confidence interval [0.22, 0.31]) years before ANSWER.
Hit rate of change detection
The hit rates of the four methods were estimated with various
series lengths and at false positive rates between 0 and 15% using
Moorfields dataset. Figure 6 demonstrates the hit rate with series
lengths of 5, 7, 9 and 11. Only the hit rates at specified false
positive rates between 0 and 15% are displayed (methods with a
higher false positive rate are not clinically useful). The areas under
the partial hit rate curves for different methods (Figure 6) were
compared in Table 1. Because the total area with false positive rate
between 0 and 15% is 0.15, the areas under the partial hit rate
curves were normalised by being divided by 0.15. Because the hit
rate of point-wise linear regression could not be estimated with a
continuous false positive rate, the area under the partial hit rate
curve was not estimated.
The methods were also compared at the 5% false positive rate,
or at the closest rate to 5% for point-wise linear regression (two
contiguous points criterion). The ratios of hit rates between pairs of
methods are shown in Table 2 where a ratio .1 indicates a better
hit rate. For instance, with series of 7 visual fields, the ratio of
ANSWERS against linear regression of mean deviation was 1.9,
indicating that the hit rate of ANSWERS is nearly twice that of the
latter method.
The hit rates of ANSWER and ANSWERS were higher than
linear regression of mean deviation and point-wise linear
regression of DLS at all series lengths. There was particular
improvement in short series. This explains the better efficiency of
ANSWER and ANSWERS to detect deterioration more quickly.
The spatial enhancement included in ANSWERS also increased the
hit rate compared with ANSWER, especially with short series.
However, this improvement became marginal as the length of
series increased.
Case studies with ANSWERS in comparison with other methods
are provided in Appendix S2.
Figure 4. Examples comparing ANSWER and ordinary linear regression. The retest distributions of corresponding differential light sensitivity
measurements are superimposed as grey areas. The scored probability densities by the ANSWER regression line are marked on the retest
distributions.
doi:10.1371/journal.pone.0085654.g004
Figure 5. Time to detect deterioration for linear regression of
mean deviation (MD), point-wise linear regression (PLR),
ANSWERS and ANSWER at false positive rates between 0 and
15%. The number of contiguous points in point-wise linear regression
are shown in the square points.
doi:10.1371/journal.pone.0085654.g005
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Discussion
ANSWERS detected change in retinal function more rapidly
than conventional statistical approaches without compromising
false positive rates. At equivalent false positive rates, it also
detected a greater number of eyes with change in retinal function
when compared to the number detected by other widely used
methods. The Weibull mixture retest distributions, in comparison
to a normally distributed error assumed in ordinary regression
models, allows ANSWERS to attain a high certainty about
deterioration status (Figure 4b). In addition, the spatial enhance-
ment aggregates information for adjacent locations in the visual
field to ‘confirm’ the spatial deterioration pattern, further
improving the method especially for short time series. This spatial
element of detecting change in visual fields has rarely been
considered before.[34–37] ANSWERS could not only aid clinical
decision for prompt treatment intervention, but also define more
efficient endpoints for clinical trials in eye-related research.[3]
The application and usefulness of ANSWERS in short series is of
particular clinical interest. Current widely used methods typified
by ordinary linear regression for change detection are limited in
short series because they can hardly reach required statistical
significance. In clinical situations, where follow-up testing is
infrequent, often due to limited resources, these standard analyses
may delay the detection of change in retinal function. In turn this
can delay required intensification of treatment. In clinical trials,
failing to pick up change in time could also lengthen the trials.
When choosing thresholds for ANSWERS to detect deterioration
in visual field series, it is critical to consider the false positive rate
for the chosen threshold of I{. In this study, the threshold was
estimated from the test-retest dataset at given false positive rates
and for each visual field series length. However, an analytical
prescription can be described theoretically and is made available
in Appendix S1. Note that I{ threshold does not change with
series length given a constant false positive rate.
The Laplace method used in ANSWERS provides local normal
approximation at the mode of the posterior slope and intercept
distribution (9), so estimations of variance of these regression
parameters may not capture every feature of the distribution
(skewness for example). Although the true posterior distribution (9)
is unknown, the estimated slope variance from the Laplace
approximation was nonetheless demonstrated to be an effective
variable in detecting change and quantifying the certainty about
change relative to other current methods.
ANSWERS was developed with the idea that it could be adapted
for other applications with similar statistical properties which are
not uncommon among other medical and biological measure-
ments. For example, serum creatinine measurement for predicting
Figure 6. The hit rates of linear regression of mean deviation (MD), point-wise linear regression (PLR), ANSWERS and ANSWER with
series lengths (length) of 5, 7, 9 and 11. The number of contiguous points in point-wise linear regression are shown in the square points. The hit
rates are estimated at false positive rates between 0 and 15%.
doi:10.1371/journal.pone.0085654.g006
Table 1. The normalised areas under partial hit rate curves for ANSWER, ANSWERS, linear regression of mean deviation (MD).
Series length =5 Series length =7 Series length =9 Series length =11
ANSWER 0.39 0.48 0.55 0.62
ANSWERS 0.41 0.49 0.56 0.62
MD 0.20 0.29 0.35 0.44
The comparison was carried out with series lengths of 5, 7, 9 and 11.
doi:10.1371/journal.pone.0085654.t001
Detecting Changes in Retinal Function: ANSWERS
PLOS ONE | www.plosone.org 9 January 2014 | Volume 9 | Issue 1 | e85654
kidney failure,[38] heart rate measurement for assessing heart
attack risk [39] and baroreceptor sensitivity feedback in diabetes
mellitus [40] pose similar challenges in clinical decision making.
There are two necessary steps in order to adapt ANSWERS for
application to other types of clinical measurements. First, the non-
stationary variability should be derived from the measurement in
question. Since the Weibull mixture distribution is versatile and
concise, it could easily be adjusted to model other retest
distributions using the expectation-maximisation algorithm pre-
sented in Appendix S1. Second, the current spatial correlation (8)
stems from the anatomy of retinal nerve fibres and therefore is not
directly applicable to measurements and conditions other than
optic neuropathies. Thus, the spatial correlation in (8) would need
to be adapted (or removed if necessary) to reflect the spatial
characteristics of the measurement or disease process in question.
Moreover, ANSWERS was used to infer linear change because
there are generally insufficient data to identify non-linear change
due to the short visual field series in clinical practice; however,
configuring ANSWERS to measure change of conditions with long
series and temporal processes showing non-linear change is trivial,
and can be done by changing the time vector ti in (6) to nonlinear
components such as radial basis functions.
In this study, test-retest data were used to estimate variability
and false positive rates. Due to the lack of gold standard about
deterioration in retinal function, these data were acquired within a
very short period of time (12 visual fields in less than 8 weeks) so it
is highly unlikely that measurable damage occurred in this period.
However, the patients that make up this dataset may gain
psychophysical experience quicker than general clinic patients who
typically undertake perimetry tests much less frequently. Therefore
patients in the test-retest data could produce measurements with
lower variability than that observed in clinical practice. However,
all methods were evaluated using the same test-retest data, hence
the false positive rates would be equivalently underestimated for
each technique. Therefore, despite the potential to underestimate
variability, test-retest data does allow us to makes a fair
comparison among the methods evaluated.
It is important to note that despite the evolution of new
statistical methods for analysing change in retinal function,
improving data acquisition techniques should continue to be at
the forefront of research. Producing less variable data at the point
of measurement acquisition will allow more accurate change
detection. Studies have already demonstrated various approaches
to improve measurements of DLS. Examples include, but are not
limited to, modulation in stimulus size,[41,42] testing in a linear
scale rather than a log scale [43] and increasing the density or
changing spatial arrangement of test points.[44,45] It was also
reported that DLS less than 15 dB is not associated with the loss of
ganglion cells and may not contain significant information about
the integrity of retinal function.[46] Therefore, there is a real need
to accurately measure changes in DLS sooner while it exceeds
15 dB.
In conclusion, ANSWERS provides a solution in a landscape of
uncertainty in detecting retinal function deterioration. This could,
for example, impact on how patients with glaucoma are monitored
and treated and the efficiency and duration of clinical trials.
ANSWERS was shown to outperform conventional methods of
detecting retinal function deterioration both in terms of statistical
sensitivity, and in time taken to detect change. ANSWERS was
demonstrated to detect visual field deterioration caused by
glaucoma, but there is plenty of scope for its use in other
measurements subject to non-stationary variability and spatial
correlation.
Supporting Information
Appendix S1 Detailed mathematical derivation. Expec-
tation-maximisation algorithm for Weibull mixture distribution,
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